Approval of Exkivity could mean NHS access to ground-breaking treatment for patients with rare lung cancer

Updated Date: Mon, 14 Mar 2022 00:00:00 EDT

Updated Date: Mon, 14 Mar 2022 00:00:00 EDT

Updated Date: Mon, 14 Mar 2022 00:00:00 EDT

The controversy over the benefits of statins is set to be aired in the High Court in London, […]

bmj;376/mar21_11/o729/FAF1faAngela Robinson was medical director of the National Blood Authority (NBA, now NHS Blood and Transplant, NHSBT) for […]

To date, eight million people in Uganda are fully vaccinated in a population of over 45 million people […]

A High Court judge has approved a “highly invasive, very unusual” medical procedure to treat a 17 year […]

Research analysed differences in treatment and survival between women and men with a heart attack and cardiogenic shock

Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed […]